Certified by Founder Lodge
Congruence Therapeutics
Canada - Montreal, Quebec
START UP
1 Disclosed Funding Rounds $65,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Congruence Therapeutics is a drug discovery company that is uniquely harnessing the power of innovative fields such as protein dynamics, biophysics, machine learning and computational chemist
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 07 ,2023 | Series A | $65,000,000 | |
| September, 05 ,2025 | Unknown | $32,000,000.00 |
Investissement Québec
OrbiMed
BDC Capital
Thrive Ventures
Amplitude Ventures
Fonds de solidarité FTQ
SilverArch Investments
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Carbon(US) | $60,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)